Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR

ConclusionsThe addition of a somatostatin analog to ongoing CBG treatment may be effective in some patients with DA-resistant macroprolactinomas, independently of the adenoma ’s SSTR expression profile.
Source: Endocrine - Category: Endocrinology Source Type: research